1. Hesse, S., and Mezger, M., 1979, Involvement of phenolic metabolites in the irreversible protein-binding of aromatic hydrocarbons: reactive metabolites of [14C]-naphtalene and [14C]-naphtol formed by rat liver microsomes, Mol. Pharmacol., 16: 667.
2. Jollow, D.J., and Smith, C., 1977, Biochemical aspects of toxic metabolites: formation, detoxication, and covalent binding, In: “Biological Reactive Intermediates,” D.J. Jollow, J.J. Kocisis, R. Snyder, and H. Vainio eds, Plenum Press, New York and London.
3. Jollow, D.J., Mitchell, D.R., Zampaglione, N., and Gillette, J.R., 1974, Bromobenzene-induced liver necrosis. Protective role of glutathione and evidence for 3,4-bromobenzene oxide as the hepatotoxic metabolite, Pharmacology, 11: 151.
4. King, H.W.S., Thompson, M.H., and Brookes, P., 1976, The role of 9-hydroxybenzo(a)pyrene to DNA, Int. J. Cancer., 18: 339.
5. Koch-Weser, D., de la Huerga, J., Yesinick, D., and Popper, H., 1953, Hepatic necrosis due to bromobenzene as an example of conditioned amino acid deficiency, Metabolism, 2: 248.